Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away from hospitals and to pharmacies and even shopping malls, a trend that will fuel exponential growth. Despite these certain trends, competition is heavy and there are issues and trends affecting this market that new entrants need to be aware of. Kalorama Information’s Lateral Flow Technology and the Future of Point of Care Diagnostics, is a perspective on the past and future of rapid clinical tests, is your guide to this increasingly crowded LF testing market place. Kalorama Information’s report cuts through the hype about the lateral flow point of care marketplace and provides a realistic assessment of this growing field. Every critical aspect of the LF market is addressed, including the following key topics:
This report provides a realistic assessment acknowledging the reality of payors’ emphasis on cost/benefit analysis for new technologies. Current sales and predictions for 2010 sales are provided for the diabetes, oncology, cardiac marker, pregnancy and other LF test markets.
Kalorama’s unique and thorough research process provides an exhaustive analysis of this evolving market. Information was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. For the purpose of this study, Kalorama Information conducted telephone and email interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with device company representatives included marketing directors, division managers, and product development representatives. In addition to superior coverage of the overall market, specific company profiles are included for the following device makers:
Related Reports: The Worldwide Market for In Vitro Diagnostic Tests, 8th Edition (pre-publication)Jul 20, 2012 - KLI3811539 - $6,500.00 The Global Market for Medical Devices, 3rd. Edition May 2, 2012 - KLI3873247 - $2,500.00 Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Apr 30, 2012 - KLI3871497 - $3,500.00 White Paper: Tests That Personalize Show Faster Revenue Growth Apr 6, 2012 - KLI3826223 - $0.00 IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics) Mar 3, 2012 - KLI2401913 - $5,995.00 Point of Care Diagnostics Bundle (POC Diagnostic Markets, POC Diagnostics for Emerging Infectious Diseases, POC Dx in Physician Office Labs) Mar 2, 2012 - KLI1946727 - $3,995.00 World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing) Mar 1, 2012 - KLI6640829 - $3,795.00 Clinical Diagnostics In Mexico: Market Analysis and Participant Directory Mar 1, 2012 - KLID6496416 - $4,500.00 The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition Jan 1, 2012 - KLI6501843 - $3,500.00 US Pharmaceutical, Medical Device, Diagnostics Markets Dec 1, 2011 - KLI6077623 - $500.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 7th Edition
IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics)
Clinical Diagnostics in India: Market Analyses and Participant Directory
Medical Imaging Markets: Molecular Imaging
White Paper - The Reality of IVD in the BRIC Nations
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
|
|||||||||
|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|